Excellent transport links via London underground, overground, DLR and Elizabeth line
30 minutes from
London City Airport
connecting you to Europe
Adjacent to the Faculty
of Medicine and Dentistry and
The Royal London Hospital
Tenants located at the QMB Innovation Centre can benefit from its central location as well as opportunities to access facilities available at Queen Mary University of London’s world-class Faculty of Medicine and Dentistry.
At QMB we support companies of various sizes. The competitively priced CL2 laboratories come in a range of sizes, from 300 to 1,200 square feet, as well as whole floor lettings of up to 11,000 square feet.
To allow easy access between laboratories and office space, we have designed integrated suites housing both laboratory and office space within each modular unit.
The commercial labs are designed to accommodate both microbiological safety cabinets and fume cupboards, allowing both biology and chemistry work. All services are kept within the ceiling void, enabling for expansion into adjacent spaces, subject to availability.
Our History
Our Past
The Queen Mary BioEnterprises (QMB) Innovation Centre offers 39,000 square feet of commercial wet laboratory and office space within Zone 2 of London. It was London’s first completely new built facility for both early and late stage chemistry and biology start-ups.
The construction of QMB was triggered as a result of visible demand for incubation space within London. The QMB project is the culmination of an investment partnership between Queen Mary University of London and the London Development Agency.
The QMB Innovation Centre is wholly owned subsidiary of Queen Mary University of London.
Since its inception in 2010, QMB has created and safeguarded over 500 science jobs within London.
Tenants located at the Innovation Centre can benefit from its central location as well as opportunities to access facilities available through our wider ecosystem, including Queen Mary University of London, Barts Life Sciences and The Blizard Institute
Meet the Team
Our Affiliates
Queen Mary University of London
Queen Mary University of London is one of the UK’s leading research-focused higher education institutions. With 25,332 students, 4,000 staff and an annual turnover of £400m, it is one of the biggest University of London colleges.
Queen Mary is a Russell Group university, operating across five campuses in London and at sites across Europe and Asia.
Queen Mary is a leading research-intensive university and was ranked fifth in the UK for the quality of research outputs (i.e. at 3* and 4* level) in the REF2014 exercise.
Queen Mary University Enterprise Zone
Queen Mary University Enterprise Zone (QME) is an innovation hub, offering flexible, modern workspace for Digital Health, MedTech and AI start-ups in East London.
Here at QME we are committed to creating the space and environment for start-ups to work, grow their venture, collaborate and pioneer new exciting innovations and are here to support start-ups on their entrepreneurial journey by connecting them to like-minded self-starters, industry experts and investors via workshops, events and networking sessions.
Flexible memberships options allow start-ups to rent a space suited to their needs, whether it’s a part time hot desk membership or a private office.
Queen Mary Innovation
Queen Mary Innovation Ltd (QMI) is Queen Mary University of London’s (QMUL) wholly-owned technology transfer company and responsible for the commercialisation and management of the University’s intellectual property and portfolio of spinout companies.
Over the last five years, QMI has secured 80 commercial licenses with industry to exploit QMUL intellectual property, returning over £1.7 million of commercial income to the University. QMI’s growing portfolio of high-growth technology spinouts has attracted in excess of £60 million of external venture capital investment.
Barts Life Sciences
Barts Life Sciences (BLS) is a partnership between Queen Mary University and Barts Health NHS Trust. BLS offers integrated access to the capabilities of both organisations, accelerating
the translation of impactful research and innovation to clinical deployment.
Working with a large, diverse population of over 2.5 million people and a growing range of industry collaborators, BLS offers a “bench to bedside” opportunity with access to a wealth of diverse data through its Precision Medicine Data Platform, capacity for phase 1-3 large-scale clinical trials in a new purpose-built facility, and availability of three national oncology biobanks.
Tenants at QMB will be part of this ecosystem, with opportunities to collaborate with other researchers and clinicians in the cluster.
